1. Home
  2. GNFT vs CLAR Comparison

GNFT vs CLAR Comparison

Compare GNFT & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • CLAR
  • Stock Information
  • Founded
  • GNFT 1999
  • CLAR 1957
  • Country
  • GNFT France
  • CLAR United States
  • Employees
  • GNFT 180
  • CLAR N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • CLAR Recreational Games/Products/Toys
  • Sector
  • GNFT Health Care
  • CLAR Consumer Discretionary
  • Exchange
  • GNFT Nasdaq
  • CLAR Nasdaq
  • Market Cap
  • GNFT 216.7M
  • CLAR 139.4M
  • IPO Year
  • GNFT 2019
  • CLAR N/A
  • Fundamental
  • Price
  • GNFT $4.31
  • CLAR $3.85
  • Analyst Decision
  • GNFT Strong Buy
  • CLAR Strong Buy
  • Analyst Count
  • GNFT 2
  • CLAR 3
  • Target Price
  • GNFT $11.00
  • CLAR $5.33
  • AVG Volume (30 Days)
  • GNFT 2.8K
  • CLAR 90.5K
  • Earning Date
  • GNFT 09-22-2025
  • CLAR 11-06-2025
  • Dividend Yield
  • GNFT N/A
  • CLAR 2.62%
  • EPS Growth
  • GNFT N/A
  • CLAR N/A
  • EPS
  • GNFT 0.03
  • CLAR N/A
  • Revenue
  • GNFT $73,187,701.00
  • CLAR $254,200,000.00
  • Revenue This Year
  • GNFT $5.44
  • CLAR N/A
  • Revenue Next Year
  • GNFT N/A
  • CLAR $4.38
  • P/E Ratio
  • GNFT $135.97
  • CLAR N/A
  • Revenue Growth
  • GNFT 105.01
  • CLAR N/A
  • 52 Week Low
  • GNFT $2.55
  • CLAR $3.02
  • 52 Week High
  • GNFT $6.42
  • CLAR $5.29
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 52.78
  • CLAR 58.23
  • Support Level
  • GNFT N/A
  • CLAR $3.45
  • Resistance Level
  • GNFT $4.30
  • CLAR $4.03
  • Average True Range (ATR)
  • GNFT 0.11
  • CLAR 0.13
  • MACD
  • GNFT -0.13
  • CLAR 0.01
  • Stochastic Oscillator
  • GNFT 100.00
  • CLAR 70.71

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: